Insights

Publication | 10.27.23

How Cos. Can Mitigate IP Risks After NY Labor Law Updates

Publication | 07.18.23

Can Pharma Firms Deduct Fees In Hatch-Waxman Suits?

Publication | 02.24.23

Genus Claims Questions After Justices Deny Juno Rehearing

Publication | 12.14.22

License Agreement Lessons From Ford Trade Secrets Case

Publication | 09.13.22

How To Minimize Risk When Launching Smart Medical Devices

Publication | 05.02.22

Patents Or Trade Secrets? How To Choose The Best IP Safeguard For R&D Assets

Publication | 04.05.22

Patentability Of Inventions Involving AI In Health Care Is Becoming A Key—And Complex—Issue

Publication | 01.26.22

CRISPR: Maximizing This Revolutionary Genetic Tool While Minimizing IP Risk

Publication | 01.12.22

BioPharma – The Calm Between the CRISPR Storms

Publication | 11.03.21

3 Practice Tips For Patenting Medical Devices In A Digital Age

Publication | 05.17.21

Early Focus On Damages Can Streamline Patent Litigation

Publication | 03.09.21

Addressing The Gender Gap In Patent Law

Publication | 09.02.20

CAFC Illumina Clarification Is Good News For Diagnostics Innovators

Publication | 05.22.20

The Regulatory Pathway To A Vaccine For COVID-19

Publication | 06.13.17

Your Corporate Intellectual Property Department Is a Value Driver

Publication | 05.13.16

Don't Hold Back: The FTC Attacks Endo for Agreeing to Delay Launch of an Authorized Generic